The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Chodon, Thinle
One or more keywords matched the following items that are connected to Chodon, Thinle
Item TypeName
Concept Melanoma, Experimental
Concept Melanoma
Academic Article A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.
Academic Article Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Academic Article MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
Academic Article CTLA4 blockade broadens the peripheral T-cell receptor repertoire.
Academic Article Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
Academic Article The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
Academic Article Identification of a novel gelsolin truncate in the vertical and metastatic phase malignant melanomas.
Academic Article CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
Academic Article Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Academic Article Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.
Academic Article Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.
Academic Article Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.
Academic Article Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.
Academic Article Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma.
Academic Article BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
Academic Article PD-1 Blockade Expands Intratumoral Memory T Cells.
Academic Article Natural killer T cells in advanced melanoma patients treated with tremelimumab.
Search Criteria
  • Melanoma